The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented.

This manual presents guidelines for clinical supervision in the substance use disorder treatment field. It covers supervision methods and models, cultural competence, ethical and legal issues, and performance monitoring. The manual also includes an implementation guide for program administrators. Access the literature review.

This guide enhances the competencies of substance use disorder treatment counselors. It discusses patient assessment and screening, treatment planning, referral, service coordination, counseling, family and community education, and cultural competency.

This guide addresses specific treatment needs of adult men living with substance use disorders. It reviews gender-specific research and best practices, such as common patterns of substance use among men and specific treatment issues and strategies.